Silk fibroin/chitosan/TGF-1-loaded microsphere scaffolds for cartilage reparation

Jin-Mei He,Peng-Fei Zhu,Li-Hua Li,Zhen Wang,Xiao-Li Li,Song Wang,Hai-Tao Ren,Chang-Sheng Chen,Bin Chu,Bo Li,Wei-Qiang Liu
DOI: https://doi.org/10.3233/BME-201178
2021-01-01
Bio-Medical Materials and Engineering
Abstract:BACKGROUND: Transforming growth factor-beta 1 (TGF-beta 1) plays an important role in chondrocyte growth and the synthesis of extracellular matrix (ECM). Due to the rapid metabolism, controlled release systems for TGF-beta 1 have attracted increasing interest recently. OBJECTIVE: In this study, a silk fibroin (SF)/chitosan (CS) scaffold incorporated with TGF-beta 1-loaded microspheres (MSs) was created for cartilage reparation. METHOD: The optimal proportion of the SF/CS composite scaffold was determined by evaluating their micromorphology and the proliferation rate of fibroblasts on the surface. Then, SF/CS/TGF-beta 1-loaded MS scaffolds were prepared by the adsorption method. TGF-beta 1 release capacity, degradation patterns, cytocompatibility and in vivo implantation were evaluted. RESULTS: The SF/CS/TGF-beta 1-loaded MS scaffold showed good TGF-beta 1 release over more than 16 days, which could sequentially stimulate chondrocyte synthetic activity. In vitro cell proliferation experiments showed the SF/CS/TGF-beta 1-loaded MS scaffold could promote chondrocytes adhesion, growth, proliferation and maintained the cellular morphology. An in vivo study demonstrated that a low inflammatory response was observed in rats and that the materials exhibited good biocompatibility. CONCLUSION: the results indicated that our SF/CS/TGF-beta 1-loaded MS scaffold constitute a promising therapeutic option for cartilage reparation.
What problem does this paper attempt to address?